This year, 162 inventors hailing from 64 NAI member institutions across the nation joined the 2025 class of NAI Senior ...
Jumbo phages use a protein shield to protect their DNA from bacterial attacks. A special handshake controls which molecules enter.
In high school, Chen immersed herself in cancer research at UC San Diego ... Chen said. The current phage therapy process is slow, but Chen said her lab aims to accelerate it and make phage ...
Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.
our scientists delved deeply into phage display technology ... of Patients with BCG-unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In Situ ImmunityBio, Inc. , a leading immunity therapy ...
Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal antibodies are derived from hybridoma technology, the recombinant antibodies are ...
leading treatment failure in many clinical indications. Increasing the efficacy and precision of chemotherapy entails molecular, that is, specific to cancer cells. To this end, we have previously ...
An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...
A patient has achieved over 18 years of remission from neuroblastoma, a type of nerve cell cancer, following treatment with ...
2d
News Medical on MSNCancer-free for 18 years: CAR-T therapy sets new milestone in neuroblastoma treatmentA groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children ...
Dr. Daniel Olson is hoping it's the first step in a whole new way of treating cancers like the one that was threatening Alla ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results